Changchun BCHT Biotechnology Co (SHSE:688276) Net Income From Continuing Operations : ¥543 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Changchun BCHT Biotechnology Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥61 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥543 Mil.

Changchun BCHT Biotechnology Co Net Income From Continuing Operations Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Net Income From Continuing Operations Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

221.02

418.24

243.55

181.54

501.01

Changchun BCHT Biotechnology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															18.38	93.00	219.71	169.92	60.57

Changchun BCHT Biotechnology Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥543 Mil.

Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines